Investor Type

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
Institutional Investor Advisor Individual Investor


Marshall Gordon Talks COVID Vaccines on Yahoo! Finance

November 16, 2020

Senior Health Care Analyst Marshall Gordon joins Yahoo! Finance to discuss the implications of positive COVID-19 vaccine trials from Pfizer and Moderna and the likely timeline for vaccine approval and availability. He points out that the equity market has likely already priced in the upside from vaccine success and discusses the impact of having several competing vaccines.   

Marshall Gordon

Senior Analyst - Health Care
21 Years experience
13 Years at ClearBridge

Related Perspectives

  • All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information. 

  • Past performance is no guarantee of future results.